| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0098 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |